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Abstract 1 
Objective: To describe the prevalence of systemic hypertension in cats with community acquired acute 2 
kidney injury (AKI) and investigate its relationship with disease severity.  3 
Methods: Retrospective study of cats presenting to the Queen Mother Hospital for Animals, Royal 4 
Veterinary College with AKI between 2007 and 2015. Systolic blood pressure (SBP) was measured 5 
using Doppler sphygmomanometry and systemic hypertension was defined as a SBP ≥150mmHg. 6 
Median SBP measurement (on admission and during hospitalisation),,IRIS (International Renal Interest 7 
Society) grade of AKI, serum creatinine on admission, the presence of anuria or oliguria, length of 8 
hospitalisation, survival to discharge and 6-month survival were all recorded.  9 
Results: Forty-six cats were eligible for inclusion. The prevalence of systemic hypertension on 10 
admission was 48.8% (21/43) and this was severe (≥180mmHg) in 18.6% (8/43) of cases. During the 11 
whole hospitalisation period, systemic hypertension was detected in 27/46 (58.7%) cases and severe in 12 
28.2% (13/46) cases. Systemic hypertension did not appear to be statistically associated with grade of 13 
kidney injury, serum creatinine on presentation, oliguria or anuria. 14 
Clinical significance: Systemic hypertension is common in cats with acute kidney injury but does not 15 
appear to be associated with its severity. 16 
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 Introduction  21 
 Acute kidney injury (AKI) is defined as an acute and abrupt decrease in kidney function resulting in 22 
abnormal glomerular filtration rate, tubular function and urine production (Hoste & Kellum 2007). AKI 23 
can be graded to encompass a continuum of functional and parenchymal damage from its least severe 24 
Grade I, a progressive increase in serum creatinine or documented oliguria over a six-hour period, to its 25 
most severe manifestation Grade V, in which renal replacement therapy may be indicated (IRIS 2013). 26 
Progressive increases in serum creatinine have been shown to be predictive of mortality in man, dogs 27 
and cats (Harison et al. 2012, Hoste et al. 2006, Uchino et al. 2010). For those patients that survive 28 
AKI, reversibility of kidney injury is variable and many patients ultimately develop chronic kidney 29 
disease (CKD; Basile 2001, Chertow et al. 2006).  30 
Systemic hypertension (SH) is a potentially serious complication of AKI in dogs and cats (Acierno & 31 
Labato 2005, Monaghan et al. 2012). The International Renal Interest Society (2015) defines systolic 32 
blood pressure (SBP) in the following categories; patients with a SBP <150 mmHg are considered 33 
normotensive, SBP of 150 to 159 mmHg are considered borderline hypertensive with a low risk of 34 
target organ damage (TOD), patients with SBP ≥160 to 179 mmHg are considered hypertensive with 35 
moderate risk of TOD and patients with SBP ≥180 mmHg have severe hypertension with high risk of 36 
TOD (IRIS 2015). The most common pathological changes reported in hypertensive cats are 37 
hypertensive choroidopathy, which can result in blindness, and hypertensive cardiac hypertrophy, 38 
which can result in a cardiac murmur or gallop rhythm (Maggio et al. 2000, Chetboul et al. 2003). A 39 
less common but severe complication of SH is hypertensive encephalopathy resulting in obtundation 40 
and seizures (Chetboul et al. 2003, Kletzmayr et al. 2003). The kidney itself has been reported to be a 41 
target organ for hypertensive injury and hypertension has been associated with progression of kidney 42 
disease in humans and dogs (Klag et al. 1996, Jacob et al. 2003, Ravera et al. 2006). 43 
SH has been documented in cats that have CKD (Syme et al. 2002) and has been described in dogs 44 
with AKI (Geigy et al. 2011). However, the prevalence of SH in feline AKI patients is currently 45 
unknown. The aims of this retrospective study were to describe the prevalence of SH in cats with AKI 46 
and to describe its relationship with disease severity and outcome.  47 
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Materials and Methods  49 
The study was approved by Royal Veterinary College Clinical Research and Ethical Review Board. 50 
The study population comprised of client-owned cats diagnosed with community-acquired azotaemic 51 
AKI referred to the Queen Mother Hospital for Animals, Royal Veterinary College between 2007 and 52 
2015. These patients were identified through a search of the hospital's computerised clinical record 53 
system. Patients were eligible for inclusion if they fulfilled the International Renal Interest Society 54 
(IRIS) guidelines for diagnosis of Grade II AKI and above, i.e. an initial serum creatinine level 55 
≥141 μmol/L and one or more of the following criteria: evidence of renal tubular injury on urinalysis 56 
(renal glucosuria, proteinuria with an inactive sediment, or renal casts), diagnostic imaging findings 57 
suggestive of AKI, or persistent urine output of less than 1 mL/kg/hour) (IRIS 2013). 58 
The files of eligible patients were reviewed and the signalment, cause of AKI, medical history 59 
(including prior medications), physical examination findings (including fundic examination), SBP 60 
measurements, patient-side electrolyte, metabolite and blood gas analysis, complete blood count, 61 
biochemistry, abdominal ultrasound, urinalysis, urine output measurements, length of hospitalisation 62 
and survival to discharge were recorded when available. The use of anti-hypertensive therapy was also 63 
documented. SBP was measured indirectly using Doppler sphygmomanometry. The standard hospital 64 
protocol for SBP measurements, adapted from the American College of Veterinary Internal Medicine 65 
guidelines (Brown et al. 2007), is to record the mean of three to five consecutive readings. 66 
SH was defined as a SBP ≥150 mmHg including cats identified as borderline hypertensive (SBP 150 to 67 
159 mmHg), hypertensive (160 to 179 mmHg) and severely hypertensive (≥180 mmHg) according to 68 
the IRIS guidelines (IRIS 2015). Patients were included if there were two or more SBP measurements 69 
within the clinical records during the period of hospitalisation. When there was more than one SBP 70 
evaluation in the clinical record on a single day of hospitalisation, a median SBP measurement for that 71 
day of hospitalisation was used for analysis. The AKI grade was determined for each patient on 72 
admission. Patients were grouped as being oliguric or anuric based on whether furosemide was 73 
administered or they underwent continuous renal replacement therapy. Patient records were analysed 74 
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and follow-up phone calls to primary care practices were performed to identify whether those patients 76 
that survived to discharge were still alive at six months. 77 
Patients were excluded if they had any history, clinicopathological data or diagnostic imaging findings 78 
suggestive of CKD including a longer history of polyuria or polydipsia, poor body condition, non-79 
regenerative anaemia or imaging evidence compatible with chronic nephropathy (small irregular 80 
kidneys and loss of corticomedullary definition). Patients were also excluded if they had concurrent 81 
diseases that could be associated with SH (including hyperthyroidism and hyperaldosteronism) or if 82 
they had a history of pretreatment with antihypertensive drugs such as angiotensin-converting enzyme 83 
inhibitors, beta-blockers or calcium channel blockers.  84 
Statistical analysis  85 
Data were assessed for normality using a Shapiro–Wilk W test and visual inspection of histograms. 86 
Normally distributed data were expressed as mean and standard deviation and non-normally distributed 87 
data expressed as median and ranges. Statistical analysis was performed using an online statistical 88 
calculator (http://www.socscistatistics.com/). Fisher's exact test was used to compare categorical data, 89 
one-way analysis of variance for ordinal data and Pearson's correlation coefficient to assess for any 90 
correlation between SBP and serum creatinine. The level of statistical significance was set at P<0·05. 91 
Results  92 
One hundred and twenty cats were presented with AKI during the investigation period. Of these, 74 93 
were excluded: 44 had incomplete data, 29 had evidence of CKD and 1 had a previous diagnosis of 94 
hyperthyroidism. Forty-six cats were eligible for inclusion in the study, of which 44 had multiple blood 95 
pressure measurements on a single day and required calculation of a median blood pressure. Of these 96 
46 cats, 13 were pedigree breeds, 27 domestic short hairs and 5 domestic long hairs and for in one the 97 
breed was not identified. Twenty-four were female neutered, 21 were male neutered and 1 cat was male 98 
entire. Ages ranged from 5 months to 13 years with a median of two years. All cats had received fluid 99 
therapy before presentation. Aetiology of AKI was determined in 38 cases: non-steroidal anti-100 
inflammatory drugs (12/46), ureteroliths (9/46), trauma (6/46), ethylene glycol (5/46), pyelonephritis  101 
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(3/46), lily ingestion (2/46) and neoplasia (1/46). In 8 of 46 cases the cause was unknown. Of the cases 103 
with ureterolithiasis, all were considered to have bilateral ureteral obstruction on review of 104 
ultrasonographic imaging. None of the cats reported to have ureteral obstruction in this study had 105 
clinical, historical or ultrasound findings specifically supporting chronic disease before the episode of 106 
AKI. 107 
Of the 46 cats, 43 had SBP measurements on the first day of hospitalisation. The prevalence of SH 108 
(SBP ≥150 mmHg) on day 1 of hospitalisation was 21 (48.8%) and in 8 (18.6%) cases this was severe 109 
(≥180 mmHg). Four cats normotensive on admission developed hypertension in hospital and did so 110 
within the first 48 hours. Out of the three cats that did not have a blood pressure measurement on the 111 
first day, two were reported to be hypertensive on their first measurement. The prevalence of SH over 112 
the whole hospitalisation period was 58·7% (n=27), which was classified as severe in 28·2% (n=13) of 113 
cases. The mean SBP of cats on day 1 was 146·6 ±28·25 mmHg and the mean SBP over the whole 114 
hospitalisation period, excluding cats that had been started on antihypertensive therapy), was 145·25 115 
±29·11 mmHg. 116 
Three cats were started on amlodipine besylate at a dose of 0·625 mg once daily. Two cats with an 117 
initial SBP over 180 mmHg were started on amlodipine on day 1 and one cat was started on amlodipine 118 
on day 2 of hospitalisation because of evidence of hypertensive retinopathy accompanying a SBP of 119 
160 mmHg. Of these three patients one was euthanased, one became borderline hypertensive and the 120 
other remained persistently hypertensive at follow-up. 121 
The mean SBP of cats on day 1 was 146.6mmHg+/-28.25 and the mean SBP over the whole 122 
hospitalisation period, excluding cats that had been started on anti-hypertensive therapy), was 123 
145.25mmHg+/- 29.11.  124 
On presentation the mean serum creatinine was 1034 ±526·99 μmol/L. Initial SBP and creatinine value 125 
on presentation were not correlated (R2 = 0.069, P = 0.078). Twenty-six cats were classified as having 126 
Grade V AKI, 16 classified as Grade IV and 2 each classified as Grades III and II AKI. There was no 127 
association between SH on presentation, IRIS AKI grade and survival (Table 1). When assessing the  128 
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prevalence of SH over the whole of the hospitalisation period there was not a statistically significant 130 
association between SH during hospitalisation, and IRIS AKI grade (Table 2). 131 
Sixteen cats were administered furosemide, two cats had peritoneal dialysis and one cat underwent 132 
continuous renal replacement therapy. There was no statistically significant association between the 133 
presence of SH and the presence of oliguria or anuria (p=0.54).  134 
Twenty-five cats were euthanased during hospitalisation of which two were borderline hypertensive, 135 
five hypertensive and seven were severely hypertensive during hospitalisation. Twenty-one cats 136 
survived to discharge of which three were classified as borderline hypertensive, four as hypertensive 137 
and six as severely hypertensive during hospitalisation. Of these, one cat was discharged to be 138 
euthanased at home and three cats were euthanased within the following six months with the remaining 139 
cats still being alive after six months. Those cats that survived had a median hospitalisation length of 140 
seven days, ranging from 1 to 18 days. 141 
Of the eight patients classified as severely hypertensive on presentation, three survived and five died. 142 
Of those cats that survived, one was persistently hypertensive at re-examination despite treatment with 143 
amlodipine, one became non-hypertensive during hospitalisation and one had incomplete records. Of 144 
those cats that died, two became borderline hypertensive on day 2 of hospitalisation, one of which was 145 
given amlodipine. The other three cats were euthanased between one and four days after admission and 146 
no follow-up SBP was recorded. Five cats developed severe SH during hospitalisation of which two 147 
were normotensive on presentation. Of these five cats, two died and three survived. Out of the three 148 
cats that survived two became less severely hypertensive, of which one became normotensive. The 149 
other cat had incomplete records. The other two cats were euthanased within 12 to 48 hours of 150 
developing severe hypertension. 151 
Discussion  152 
This retrospective study shows that SH, including cats with borderline hypertension, is common in cats 153 
with AKI with a prevalence of 58·7% over the course of hospitalisation; in 28·2% of cases the 154 
hypertension was classified as severe. SH in cats has most extensively been described in patients with  155 
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CKD where studies report a prevalence varying between 19.8% and 65% (Syme et al. 2002, Stiles et al. 157 
1994) depending on criteria used to define hypertension. with a prevalence varying between 19·8 and 158 
65% (Stiles et al. 1994, Syme et al. 2002) depending on criteria used to define hypertension. Previous 159 
studies of feline AKI have attempted to assess prognosis and severity indices (Lee et al. 2012, Segev et 160 
al. 2013) but have not examined the prevalence of SH in detail. Segev et al. (2013) reported a 161 
prevalence of SH (defined as SBP >150 mmHg) of 38%, but included cats with “acute-on-chronic” 162 
kidney disease. Furthermore, the frequency and technique for SBP measurement was not detailed, 163 
therefore direct comparison with the current study is not possible. 164 
In our study 54·3% of cats were euthanased in hospital, of which 56% were classified as either 165 
borderline or severely hypertensive. SBP did not appear to be correlated with IRIS AKI grade or serum 166 
creatinine at presentation. This suggests that SH in cats with AKI is not necessarily related to severity 167 
of azotaemia and AKI grade. These findings are in line with the studies of CKD in cats in which 168 
hypertension has not been found to be associated with survival or a progressive phenotype of CKD 169 
(Syme et al. 2002, Jepson et al. 2007, Bijsmans et al. 2015). In contrast, in humans and dogs, 170 
hypertension has been associated with progression of renal disease (Klag et al. 1996, Wehner et al. 171 
2008). 172 
Due to the small sample size and the various confounding factors of outcome including the variable 173 
prognosis of the different causes of AKI, owner finances and other co-morbidities, the association 174 
between SH and outcome could not be reliably assessed. Failure to see evidence of an association 175 
between SH and severity of AKI in this study may have been due to using creatinine as the sole 176 
indicator of kidney function [recognised to be problematic for multiple reasons including variation in 177 
hydration status and body condition between patients (Braun et al. 2003)] or the result of a type II 178 
statistical error. 179 
Although hypertension is common in kidney disease its pathogenesis is poorly understood. Suggested 180 
aetiologies in humans have included volume-impaired excretion of sodium, leading to volume 181 
overload, excessive activation of the renin-angiotensin-aldosterone system, stimulation of the 182 
sympathetic nervous system, reduced bioavailability of the endothelial vasodilator, nitric oxide and  183 
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increased production of the vasoconstrictor endothelin and increase in reactive oxygen species 185 
(Campese et al. 2006, Pouchelon et al. 2015). To date there have been no studies of pathogenesis of SH 186 
in AKI in cats and even in CKD the pathogenesis remains poorly explained. In this study there was no 187 
association between anuria and SH. As these are the patients that are most susceptible to volume 188 
overload it could be hypothesised that volume overload was not an important cause of hypertension in 189 
this population of cats. However, improved data in terms of clinical signs relating to volume overload 190 
such as baseline body weights and body weight changes and urine output as well as an assessment of 191 
volume status (e.g. utilising bioimpedence) would be required to better evaluate this hypothesis. 192 
Adverse effects on the ophthalmic, cardiovascular and central nervous systems has been reported in 193 
cats with hypertension (Jepson 2011). In this study, one patient had signs consistent with hypertensive 194 
retinopathy–choroidopathy. However, this was the only patient that had written documentation of a 195 
fundic examination having been performed and so the true prevalence of ocular manifestations of SH 196 
in these AKI patients cannot be reported with confidence. Nevertheless, ophthalmic examination 197 
should be recommended for patients with AKI if there is suspicion of SH and future studies should 198 
include evaluation for hypertensive ocular damage. 199 
There are a number of limitations to this study. First, the strict inclusion criteria, particularly the 200 
exclusion of those patients with acute on CKD reduced the sample size and overall power of the study. 201 
Important records such as fundic examination findings, baseline body weights, daily weight changes 202 
and accurate urine output measurements were lacking in some cases, preventing further assessment of 203 
fluid overload and its effect on development of SH in the hospital. Urine output measurement is 204 
required for early IRIS AKI grading and to accurately diagnose a patient as anuric or oliguric and has 205 
been shown to be a prognostic factor in AKI in humans (Behrend & Miller 1996). This study did not 206 
enrol patients with IRIS AKI Grade I, and only captured two patients with IRIS AKI Grade II reducing 207 
the data distribution and therefore making it possible that the lack of association between IRIS grade 208 
and SH results from type II statistical error. The IRIS grading system itself is a useful guide for 209 
determining severity of disease but it has not yet been validated for use in AKI. 210 
 211 
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In the current study, we attempted to exclude those patients with acute-on-chronic disease based on 213 
recorded historical, physical examination and ultrasound findings. Patients with ureteroliths, without 214 
documented historical, physical examination and ultrasonographic findings consistent with CKD were 215 
included. However, due to the pathophysiology of obstructive disease and retrospective nature of the 216 
study we cannot exclude the -possibility that these patients did not have underlying subclinical CKD 217 
and therefore inadvertently included some acute-on-chronic causes of AKI. 218 
Of particular concern in this study, is the “white coat effect,” especially in those patients with fewer 219 
blood pressure readings in their clinical records. White-coat hypertension, an increase in blood pressure 220 
as a result of adrenergic stimulation during situations of stress, anxiety or excitement, has been 221 
documented in healthy cats during simulated visits to a veterinary clinic (Belew et al. 1999). In an 222 
attempt to minimise this effect on the findings of this study, when multiple blood pressure recordings 223 
were recorded on a single day of hospitalisation a median SBP reading for that day was used for the 224 
analysis. However, in some patients only a single blood pressure reading was performed on any 225 
particular day and these patients therefore carry greater risk of inappropriate classification. Due to the 226 
retrospective nature of the study there was limited information on the circumstances surrounding blood 227 
pressure measurement and the clinician's perspective on the accuracy of the single blood pressure 228 
readings. Assessment for hypertensive retinopathy–choroidopathy in all patients would have been 229 
useful to assess for evidence of TOD as part of exclusion criteria for white-coat hypertension and, 230 
ideally, continuous blood pressure monitoring would be required to completely mitigate the white-coat 231 
effect. 232 
In summary, this study suggests SH is common in cats with AKI. However, it does not appear to be 233 
associated with disease severity or magnitude of azotaemia. This study should be considered a 234 
preliminary study for future prospective studies assessing hypertension in AKI, its persistence during 235 
hospitalisation and the effect of antihypertensive treatment on outcome. 236 
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Table 1: Classification of systemic hypertension at presentation and its association with Acute 326 
Kidney Injury grade and survival  327 
SBP at 
presentation 
(mmHg) 
Total percentage 
(%) 
Number of cats 
Survival to 
discharge 
IRIS AKI grade 
II III IV V 
150 to 159 6/21 (28.57%) 0 0 2 4 
2/6 
(33.33%) 
160 to 179 7/21 (33.33%) 0 0 5 2 
3/7 
(42.85%) 
≥180 8/21 (38.09%) 0 2 1 5 
3/8 
(37.5%) 
SBP: Systolic blood pressure; IRIS: International Renal Interest Society  AKI: Acute Kidney Injury  328 
Table 2: Association between IRIS AKI grade and presence of hypertension (defined as 329 
systolic blood pressure ≥ 150mmHg) during hospitalisation.  330 
IRIS AKI grade 
Number of 
patients 
Mean SBP 
(mmHg) 
II 2 127 ±9·89  
III 2 193·75 ±8·84  
IV 16 148·28 ±23·92 
V 26 158·48 ±28·28 
n= 46, p= 0.056  331 
IRIS: International Renal Interest Society; AKI: Acute Kidney Injury; SBP: Systolic blood pressure  332 
